Recurrent osteomyelitis. Report of four cases culturing L-form variants of Staphylococci.
D000293:Adolescent; D000328:Adult; D002511:Cephalosporins / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D002908:Chronic Disease; D003470:Culture Media; D013293:Enterococcus faecalis / Q000187:drug effects; D004917:Erythromycin / Q000494:pharmacology; D005260:Female; D005264:Femoral Fractures / Q000000981:diagnostic imaging; D005270:Femur Head / Q000098:blood supply; D006801:Humans; D006982:Hypertonic Solutions; D007612:Kanamycin / Q000494:pharmacology; D007740:L Forms; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009336:Necrosis / Q000209:etiology; D010019:Osteomyelitis / Q000150:complications / Q000209:etiology*; D010406:Penicillins / Q000494:pharmacology; D011113:Polymyxins / Q000494:pharmacology; D011511:Proteus / Q000187:drug effects; D011859:Radiography; D013203:Staphylococcal Infections / Q000382:microbiology*; D013210:Staphylococcus / Q000187:drug effects; D013752:Tetracycline / Q000494:pharmacology; D014640:Vancomycin / Q000494:pharmacology
D002511:Cephalosporins; D003470:Culture Media; D006982:Hypertonic Solutions; D010406:Penicillins; D011113:Polymyxins; D007612:Kanamycin; D004917:Erythromycin; D002701:Chloramphenicol; D014640:Vancomycin; D013752:Tetracycline